Presentations

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarker for enrichment in clinical trials for pre-dementia stages of Alzheimer’s disease

Conrado, D.J., et al.; “The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarke

D-RSC presents poster and talks about data standards at the Duchenne Connect Conference

D-RSC presents at the PPMD Connect Conference

The FDA is Listening: Integrating the Voice of the Patient in Drug Development for Parkinson’s and Huntington’s Diseases

The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine

Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease

Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards: Extension to Biometric Monitoring Device (BMD) Assessments

Arnerić, S.P., et al.; “Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards:

The Coalition Against Major Diseases: Expanding its clinical trial database to support a disease progression model for pre-dementia

Romero, K., et al.; “The Coalition Against Major Diseases: Expanding its clinical trial database to support a disease progressio

D-RSC Presents Poster at 2017 MDA Scientific Conference

April 11, 2016

Electronic Capture of Clinical Outcome Assessment Data: Why Is It Not Used More in Clinical Studies

Previous1011 12...14 Next